Watch Video
Share
February 23, 2022
Edgewise Therapeutics President & CEO Kevin Koch joins Jill Malandrino on Nasdaq #TradeTalks to discuss rare muscle disorder treatment and the company’s pipeline. #EveryVoiceMatters #RAREDC2022
#nasdaq #stockmarket #stocks #finance #financial #trading #trader #stock
Posts